Esperion shares surge on cholesterol drug submissions in Canada

ESPR Stock  USD 1.85  0.04  2.12%   
Slightly above 67% of Esperion Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Esperion Therapeutics suggests that many traders are alarmed. Esperion Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Esperion Therapeutics. Many technical investors use Esperion Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Esperion shares surge on cholesterol drug submissions in Canada

Read at investing.com
Investing News at Macroaxis
  

Esperion Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Esperion Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Esperion Therapeutics Fundamental Analysis

We analyze Esperion Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Esperion Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Esperion Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

Esperion Therapeutics is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Esperion Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Esperion Therapeutics stock to make a market-neutral strategy. Peer analysis of Esperion Therapeutics could also be used in its relative valuation, which is a method of valuing Esperion Therapeutics by comparing valuation metrics with similar companies.

Peers

Esperion Therapeutics Related Equities

PBHPrestige Brand   14.78   
0%
100.0%
PAHCPhibro Animal   9.88   
0%
66.0%
LFCRLifecore Biomedical   1.83   
0%
12.0%
COLLCollegium Pharmaceutical   0.78   
0%
5.0%
ANIPANI Pharmaceuticals   0.64   
0%
4.0%
ITCIIntracellular   0.07   
0%
1.0%
ALKSAlkermes Plc   0.25   
1.0%
0%
NBIXNeurocrine Biosciences   0.46   
3.0%
0%
ELANElanco Animal   0.50   
3.0%
0%
SIGASIGA Technologies   1.53   
10.0%
0%
KMDAKamada   1.71   
11.0%
0%
RMTIRockwell Medical   1.98   
13.0%
0%
PCRXPacira BioSciences,   3.06   
20.0%
0%
AVDLAvadel Pharmaceuticals   3.96   
26.0%
0%
IRWDIronwood Pharmaceuticals   8.06   
54.0%
0%

Additional Tools for Esperion Stock Analysis

When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.